← Back to Search
Distribution And Elimination Of Coated Polymethyl [2-14C]methacrylate Nanoparticles After Intravenous Injection In Rats.
D. Leu, B. Manthey, J. Kreuter, P. Speiser, P. Deluca
Published 1984 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Surfactant-coated polymethyl [2-14C]methacrylate nanoparticles had significantly different time-course distribution patterns in rats than noncoated and albumin-coated particles. Blood concentrations of poloxamer 188-coated particles were 70-fold higher after 30 min, and the particles persisted at higher levels in the circulation for up to 2 h. The initial and final liver levels were significantly lower (38% after 30 min, 51% after 7 d) and spleen levels were significantly higher (21% after 30 min, 23% after 7 d) than non-coated particles (74% in the liver and 5% in the spleen after 7 d) and the albumin-coated particles (84% in the liver and 5% in the spleen after 7 d). Specific activity was somewhat higher for the surfactant-coated particles in other organs such as the lungs, kidneys, testicles, ovaries, and lymph nodes. The bovine serum albumin sorption behavior of polymethyl methacrylate nanoparticles was followed under various conditions, and adsorption was found to increase with increasing protein concentration and increasing temperature, reaching a maximum at the isoelectric point of pH 4.9 after approximately 12 h of incubation. The zeta potential of the particles decreased with increasing pH, and the change was more pronounced with the albumin-coated particles.
This paper references
Physicochemical characterization of polyacrylic nanoparticles
J. Kreuter (1983)
Actinomycin D absorbed on polymethylcyanoacrylate nanoparticles: increased efficiency against an experimental tumor.
F. Brasseur (1980)
Physiology and physiopathology of the reticuloendothelial system.
T. Saba (1970)
Distribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice.
J. Kreuter (1979)
Structural changes in proteins adsorbed on polymer surfaces
M. E. Soderquist (1980)
Acute hemodynamic effects and blood pool kinetics of polystyrene microspheres following intravenous administration.
J. Slack (1981)
Acrylic microspheres in vivo. I. Distribution and elimination of polyacrylamide microparticles after intravenous and intraperitoneal injection in mouse and rat.
I. Sjoeholm (1979)
Evaluation of nanoparticles as drug-delivery systems. II: Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter greater than 1 micron), liposomes, and emulsions.
J. Kreuter (1983)
Protein measurement with the Folin phenol reagent.
O. H. Lowry (1951)
Nanocapsules: A new type of lysosomotropic carrier
P. Couvreur (1977)
CARCINOGENESIS THROUGH SOLID STATE SURFACES.
F. Bischoff (1964)
L-Asparaginase Immobilized within Semipermeable Microcapsules: in vitro and in vivo Stability
T. Chang (1972)
Initial events in interactions of blood with a foreign surface.
R. Baier (1969)
Subcutaneous Carcinogenesis by 14C and 3H Labelled Polymethylmetacrylate Films *
L. Tomatis (1966)
Gel entrapped L-asparaginase: kinetic behavior and antitumor activity.
K. O'driscoll (1975)
Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration.
S. Illum (1983)
Acrylic Cement in Orthopaedic Surgery
J. Charnley (1970)
Polymerized micelles and their use as adjuvants in immunology.
G. Birrenbach (1976)
Nanoparticles--a new colloidal drug delivery system.
J. Marty (1978)
The adsorption of human plasma albumin and bovine pancreas ribonuclease at negatively charged polystyrene surfaces: I. Adsorption isotherms. Effects of charge, ionic strength, and temperature
W. Norde (1978)
Distribution of radiolabeled subvisible microspheres after intravenous administration to beagle dogs.
H. Schroeder (1978)
Further Studies of Polymers as Carcinogenic Agents in Animals
G. Tarnowski (1955)
New adjuvants on a polymethylmethacrylate base.
J. Kreuter (1976)
Clearance of 141C3-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs.
M. Kanke (1980)
This paper is referenced by
Poly(glycerol adipate) - indomethacin conjugates for modified drug release
T. Wersig (2019)
SÍNTESE DE POLÍMEROS GLICOSILADOS E APLICAÇÃO COMO COMPONENTES DE NANOPARTÍCULAS PARA VETORIZAÇÃO DE FÁRMACOS
Bruna Donida (2010)
Influence of polybutylcyanoacrylate nanoparticles and liposomes on the efficacy and toxicity of the anticancer drug mitoxantrone in murine tumour models.
P. Beck (1993)
Size and morphological analysis of albumin microspheres in the lungs and liver of mice
K. Lee (1988)
Hemocompatibility of Nanoparticles
S. J. Evani (2011)
Possibilities of using nanoparticles as carriers for drugs and vaccines.
J. Kreuter (1988)
Influence of interfacial properties on perfluorocarbon/aqueous emulsion stability
D. Burgess (1995)
An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes.
J. C. Leroux (1995)
Nanoparticle drug delivery system for restenosis
V. Labhasetwar (1997)
in vivo targeting of colloidal carriers by novel graft copolymers
R. Arshady (1996)
In vivo performance of parenteral theophylline-loaded polyisobutylcyanoacrylate nanoparticles in rats.
M. A. Radwan (1999)
Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.
P. Sharma (2010)
Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectives
P. Couvreur (1991)
Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity
Y. Lee (2015)
Microspheres for biomedical applications: preparation of reactive and labelled microspheres.
R. Arshady (1993)
Mechanism of adsorption of human albumin to titanium in vitro.
A. Klinger (1997)
Synthesis of nanoparticles and nanocapsules for controlled release of the antitumor drug "Arglabin" and antituberculosis drugs
L. Zhaparova (2012)
Monoclonal antibodies covalently coupled to polymethacrylic nanoparticles: in vitro specific targeting to human T lymphocytes
A. Rolland (1987)
Biodegradable PEGylated microspheres and nanospheres
V. Sinha (2004)
Nanoparticulate systems as drug carriers: the need
V. Patravale (2012)
Contact angles of surfactants with a potential to alter the body distribution of colloidal drug carriers on poly(methyl methacrylate) surfaces
S. Tröster (1988)
Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages
H. Nabeshi (2011)
Nanoparticle based strategies for the treatment of Glioblastoma
F. A. Fisusi (2014)
Nanoparticle-based dmg delivery systems
J. Kreuter (1991)
Drug release characteristics of unimolecular polymeric micelles.
H. Liu (2000)
Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems
N. Liptrott (2018)
The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages
L. Ilium (1986)
Biodegradable Indium-111 Labeled Microspheres for in Vivo Evaluation of Distribution and Elimination
B. C. Thanoo (2004)
Tumor-inhibitory effect and immunomodulatory activity of fullerol C60(OH)x.
Jiadan Zhu (2008)
Biodistribution of poly(butyl 2-cyanoacrylate) nanoparticles in rabbits
S. J. Douglas (1986)
Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants
S. Tröster (1990)
A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery
E. Poyner (1995)See more